Baxter’s IV Fluid Production Halted Indefinitely Due to Hurricane Helene Damage

Baxter International's North Carolina factory was severely damaged by Hurricane Helene, leading to an indefinite halt in IV fluid production.
The facility is one of the largest suppliers of IV fluids in the U.S., accounting for approximately 60% of the country's IV fluid bags.
Hospitals are rationing IV fluids and employing conservation strategies, including using alternative hydration methods and rescheduling elective surgeries.
Baxter has not provided a specific timeline for when production might resume, but experts predict it could take several weeks or even months.
The FDA is collaborating with Baxter and other government entities to manage the situation, including considering temporary importation of IV fluids to mitigate shortages.
Hospitals are revisiting strategies used during similar shortages in 2017, following Hurricane Maria, to manage the current crisis.
Other manufacturers, such as B. Braun and ICU Medical, are ramping up production to help cover the shortage.